Jeg ønsker at alle leser dette innlegget.
I wish that everyone read this post.
It is a breaking news for mankind.!
----------
(from https://plus.google.com/108680220298301128882/posts/aNqzqT3jnEa)
FDA LIFTS BAN ON BURZYNSKI
It was announced last week that the Food & Drug Administration (FDA) has lifted all its previous sanctions against The Burzynski Research Institute, Inc. (BRI)—now encouraging BRI to commence with Phase 3 clinical trials to lead this therapy into the open market. BRI's stock jumped from $0.03 to $0.14 a share within days of this announcement.
The Wall Street Journal press release: http://online.wsj.com/article/PR-CO-20140623-907787.html
As most of you know, Burzynski's Holy Grail has been the fact that his invention is the first and only medication to ever cure a diffuse intrinsic brainstem glioma in children. On top of that, Antineoplastons are also the first and only medication to show enough safety and efficacy to ever reach FDA-approval for a Phase 3 trial for this condition. If Antineoplastons (ANP) were approved for this condition, it could create a massive shift in traditional cancer therapy worldwide—as people would begin to request these medications "off-label" by default, even if insurance doesn't cover it.
In celebration of this, both parts of "Burzynski: Cancer Is Serious Business" has been made available online free of charge until July 15.
Part I: http://vimeo.com/24821365
Part II: http://vimeo.com/69209285
I wish that everyone read this post.
It is a breaking news for mankind.!
----------
(from https://plus.google.com/108680220298301128882/posts/aNqzqT3jnEa)
FDA LIFTS BAN ON BURZYNSKI
It was announced last week that the Food & Drug Administration (FDA) has lifted all its previous sanctions against The Burzynski Research Institute, Inc. (BRI)—now encouraging BRI to commence with Phase 3 clinical trials to lead this therapy into the open market. BRI's stock jumped from $0.03 to $0.14 a share within days of this announcement.
The Wall Street Journal press release: http://online.wsj.com/article/PR-CO-20140623-907787.html
As most of you know, Burzynski's Holy Grail has been the fact that his invention is the first and only medication to ever cure a diffuse intrinsic brainstem glioma in children. On top of that, Antineoplastons are also the first and only medication to show enough safety and efficacy to ever reach FDA-approval for a Phase 3 trial for this condition. If Antineoplastons (ANP) were approved for this condition, it could create a massive shift in traditional cancer therapy worldwide—as people would begin to request these medications "off-label" by default, even if insurance doesn't cover it.
In celebration of this, both parts of "Burzynski: Cancer Is Serious Business" has been made available online free of charge until July 15.
Part I: http://vimeo.com/24821365
Part II: http://vimeo.com/69209285
No comments:
Post a Comment